跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 133 条关于
“LGMD-2C”
全部
133
临床试验
49
药物
38
机构
3
资讯
43
去年
Atamyo Therapeutics' ATA-200 Gene Therapy Receives FDA Clearance for US Clinical Trial in LGMD2C/R5
2年前
Atamyo Therapeutics Advances Gene Therapy Programs for Limb-Girdle Muscular Dystrophy
6个月前
Atamyo Therapeutics Reports Promising Early Results for ATA-200 Gene Therapy in Rare Muscular Dystrophy
去年
FDA Clears Atamyo's ATA-200 Gene Therapy Trial for LGMD2C/R5 in Children
去年
LGMD Therapeutics: Competitive Landscape and Pipeline Analysis
上个月
LGMD Advocates From 20+ States Press Congress as First Subtype Treatment Nears
去年
First Patient Dosed in Phase 1 Trial of ABS-0871 for Charcot-Marie-Tooth Disease 2C Treatment
去年
CureLGMD2i and myTomorrows Partner to Enhance Clinical Trial Access for Limb-Girdle Muscular Dystrophy Patients
去年
atai Life Sciences Secures $11.4 Million NIH Grant for Non-Hallucinogenic Opioid Use Disorder Treatment
去年
AskBio's AB-1003 Receives FDA Rare Pediatric Disease and Orphan Drug Designations for LGMD2I/R9
第 1 页,共 5 页
上一页
下一页